Featured Research

from universities, journals, and other organizations

First Large Scale Screening To Identify Host Genes Involved In Malaria Infection

Date:
November 7, 2008
Source:
University of Institute of Molecular Medicine, Faculty of Medicine Lisbon
Summary:
Researchers screened more that 700 molecules by RNAi to identify host factors involved in malaria infection.

Researchers at Instituto de Medicina Molecular in Lisbon, Portugal, screened more that 700 molecules by RNAi to identify host factors involved in malaria infection.

The researchers of the Malaria Unit at Instituto de Medicina Molecular (IMM, Lisbon, Portugal) has publish in the peer reviewed journal PLoS Pathogens the results of a large scale screening of more than 700 genes to identify host factors involved in the liver stage of malaria infection. The study is based on the application of RNA interference technology (RNAi technology), which allows the repression of specific genes, and in the use of fluorescence microscopy to monitor the effect of the gene repression on the liver stage of malaria infection.

The study was developed by Miguel Prudκncio, Cristina Rodrigues and colleagues at the IMM Malaria Unit, directed by Maria Mota. Part of the study was conducted at the biotech company Cenyx (Dresden, Germany), a worldwide leader in RNAi technology.

The large scale screening focused on genes involved in signaling pathways (which allow cells to receive, and respond to, external stimuli), and led to the identification of at least 5 proteins whose inhibition causes reduction of malaria infection at the liver stage. The liver stage of malaria infection is the initial step of host invasion by the malaria parasite and is determinant to the replication of the parasite, preceding the appearance of the symptoms of the disease.

“The idea now is to unravel how these host proteins influence the malaria infection, to understand in which molecular mechanisms they participate”, says Miguel Prudencio.

“The screening is, in itself, an important step in malaria research , but is also the beginning of further research”, says Cristina D. Rodrigues.

The characterization of the molecular mechanisms of infection in which the proteins now identified participate is presently one of the research lines of IMM Malaria Unit.

The present study highlights the competitiveness of the IMM Malaria Unit, which has been able to attract important international funding. “This study was possible only with the substantial funding of the European Science Foundation, which contributed substantially to the funding of our research team through the EURY programme”, says Maria Mota. “This publication is the result of an enormous research and financial effort from our laboratory”, continues Maria Mota.


Story Source:

The above story is based on materials provided by University of Institute of Molecular Medicine, Faculty of Medicine Lisbon. Note: Materials may be edited for content and length.


Cite This Page:

University of Institute of Molecular Medicine, Faculty of Medicine Lisbon. "First Large Scale Screening To Identify Host Genes Involved In Malaria Infection." ScienceDaily. ScienceDaily, 7 November 2008. <www.sciencedaily.com/releases/2008/11/081107072033.htm>.
University of Institute of Molecular Medicine, Faculty of Medicine Lisbon. (2008, November 7). First Large Scale Screening To Identify Host Genes Involved In Malaria Infection. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/11/081107072033.htm
University of Institute of Molecular Medicine, Faculty of Medicine Lisbon. "First Large Scale Screening To Identify Host Genes Involved In Malaria Infection." ScienceDaily. www.sciencedaily.com/releases/2008/11/081107072033.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins